Parkwood LLC’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-173,975
| Closed | -$14.6M | – | 90 |
|
|
2024
Q3 | $14.6M | Buy |
173,975
+2,572
| +2% | +$203K | 1.03% | 20 |
|
|
2024
Q2 | $13.2M | Buy |
171,403
+559
| +0.3% | +$40.9K | 1.64% | 13 |
|
|
2024
Q1 | $11.7M | Buy |
170,844
+97,471
| +133% | +$6.27M | 1.05% | 22 |
|
|
2023
Q4 | $4.24M | Sell |
73,373
-6,531
| -8% | -$349K | 0.51% | 52 |
|
|
2023
Q3 | $4.22M | Buy |
79,904
+10,434
| +15% | +$547K | 0.46% | 49 |
|
|
2023
Q2 | $3.76M | Sell |
69,470
-3,560
| -5% | -$186K | 0.68% | 43 |
|
|
2023
Q1 | $3.65M | Buy |
73,030
+7,474
| +11% | +$352K | 0.5% | 53 |
|
|
2022
Q4 | $3.03M | Sell |
65,556
-6,997
| -10% | -$303K | 0.46% | 55 |
|
|
2022
Q3 | $2.81M | Buy |
72,553
+9,569
| +15% | +$384K | 0.43% | 55 |
|
|
2022
Q2 | $2.35M | Sell |
62,984
-120,871
| -66% | -$4.92M | 0.42% | 62 |
|
|
2022
Q1 | $8.14M | Buy |
183,855
+56,735
| +45% | +$2.46M | 1.33% | 19 |
|
|
2021
Q4 | $5.4M | Sell |
127,120
-2,634
| -2% | -$111K | 0.92% | 41 |
|
|
2021
Q3 | $5.63M | Buy |
129,754
+1,918
| +2% | +$84.9K | 0.68% | 38 |
|
|
2021
Q2 | $5.47M | Sell |
127,836
-9,942
| -7% | -$418K | 0.63% | 44 |
|
|
2021
Q1 | $5.33M | Buy |
137,778
+24,573
| +22% | +$930K | 0.94% | 37 |
|
|
2020
Q4 | $4.07M | Buy |
113,205
+80,226
| +243% | +$2.89M | 0.49% | 61 |
|
|
2020
Q3 | $713K | Sell |
32,979
-94,397
| -74% | -$3.64M | 0.11% | 83 |
|
|
2020
Q2 | $4.47M | Buy |
127,376
+25,934
| +26% | +$934K | 0.8% | 46 |
|
|
2020
Q1 | $3.31M | Buy |
+101,442
| New | +$3.96M | 0.67% | 49 |
|
|
2019
Q4 | – | Sell |
-119,765
| Closed | -$4.87M | – | 80 |
|
|
2019
Q3 | $4.87M | Sell |
119,765
-21,537
| -15% | -$912K | 0.98% | 39 |
|
|
2019
Q2 | $6.07M | Sell |
141,302
-12,271
| -8% | -$472K | 1.3% | 26 |
|
|
2019
Q1 | $5.89M | Buy |
153,573
+2,718
| +2% | +$104K | 1.15% | 28 |
|
|
2018
Q4 | $5.33M | Sell |
150,855
-11,479
| -7% | -$416K | 1.22% | 28 |
|
|
2018
Q3 | $6.25M | Buy |
+162,334
| New | +$5.67M | 1.06% | 28 |
|
|
2017
Q1 | – | Sell |
-18,571
| Closed | -$402K | – | 503 |
|
|
2016
Q4 | $402K | Buy |
18,571
+6,875
| +59% | +$150K | 0.06% | 230 |
|
|
2016
Q3 | $278K | Sell |
11,696
-6,128
| -34% | -$146K | 0.04% | 385 |
|
|
2016
Q2 | $417K | Hold |
17,824
| – | – | 0.07% | 299 |
|
|
2016
Q1 | $335K | Sell |
17,824
-19,791
| -53% | -$348K | 0.06% | 371 |
|
|
2015
Q4 | $694K | Hold |
37,615
| – | – | 0.11% | 120 |
|
|
2015
Q3 | $617K | Buy |
+37,615
| New | +$643K | 0.1% | 123 |
|
|
2014
Q1 | – | Sell |
-6,973
| Closed | -$84K | – | 199 |
|
|
2013
Q4 | $84K | Buy |
+6,973
| New | +$82.4K | 0.02% | 521 |
|
Other funds holding BSX
Parkwood LLC's BSX Position: Q4 2024 in Review
Parkwood LLC sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 173,975 shares — an estimated $14.6M sold.
Parkwood LLC first reported a position in BSX in Q4 2013 and held it in 31 quarters. The position peaked at $14.6M in Q3 2024. 1,513 funds tracked by Wall St. Rank hold BSX as of Q4 2024.
- Parkwood LLC reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
- Parkwood LLC sold 173,975 Boston Scientific shares in Q4 2024, an estimated $14.6M.
- Parkwood LLC first reported a position in Boston Scientific in Q4 2013 and held it in 31 quarters.
- Parkwood LLC's Boston Scientific position peaked at $14.6M in Q3 2024.
- 1,513 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.
Based on Parkwood LLC's 13F filing for Q4 2024, filed 14 Feb 2025.